kiran mazumdar shaw is the chairman

8/6/2019 Kiran Mazumdar Shaw is the Chairman

http://slidepdf.com/reader/full/kiran-mazumdar-shaw-is-the-chairman 1/8

Kiran Mazumdar Shaw is the Chairman & Managing Director of Biocon Ltd, India's

biggest biotechnology company. In 2004, she became India's richest woman. Kiran Mazumdar Shaw was

born on March 23, 1953 in Bangalore.

Education:

She had done her schooling at Bishop Cotton Girls School and Mount Carmel College at Bangalore. After doing completing her B.Sc. in Zoology from Bangalore University in 1973, she went to Ballarat University

in Melbourne, Australia and qualified as a master brewer.

Career

Kiran Mazumdar Shaw begin with her professional career as the trainee in brewer in Carlton

& United Beverages in 1974. In the year 1978, she joined as Trainee Manager with Biocon

Biochemicals Limited in Ireland. In the same year, Kiran Mazumdar Shaw led the founded Biocon India

in collaboration with Biocon Biochemicals Limited, with an initial capital of Rs.10, 000

Biocon¶s initial operation was only to extract an enzyme from papaya. Under the guidance of Kiran

Mazumdar Shaw¶s stewardship Biocon transformed from an industrial enzymes company to an integrated

biopharmaceutical company with strategic research initiatives.

Awards

These include ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst &

Young¶s Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding

Citizen, Technology Pioneer, etc. Government of India also felicitated her with Padmashri (1989) and

Padma Bhushan (2005).

Kiran Mazumdar Shaw inspires her team with a shared vision of the future. Transformed them into, and

efficient workforce, she don¶t necessarily lead from the front, as she loves t to delegate responsibility

amongst their teams. While their enthusiasm is often infectious, they can need to be supported by

³people´.

In Biocon, both transactional and transformational leadership has been seen. The transactional leaders

(or managers) ensure that routine work is done reliably, while the transformational leaders look after

initiatives that add value. High regulating and low nurturing has seen as the key factor of her behavior,

she always defines the role of the group members telling them what task to do and how and when and

where to do them. She is the master of her field so she has developed her trade like that.

She always initiates the problem solving and decision making are solely by her even the solution and

decision are announced by her and its implementations are closely supervised by her. The above

behavior keeps her under the authoritative and directive leadership trade. Kiran Mazumdar Shaw isknown as her authority under her leadership Biocon has immerged as the most admired company in

biotechnology for their research work and wealth creation. She is the great believer in herself and always

led the research project under her umbrella.Biocon wins Bio-Excellence Award for Outstanding Achievement in

the Healthcare Sector at Bangalore Bio

2009



Biocon among Top 20 Indian companies in Forbes µBest Under ABillion¶ list.

Biocon wins Bio-Excellence Award for Outstanding Achievement inthe Healthcare Sector at Bangalore Bio

Syngene wins Bio-Excellence Award for outstanding achievement

in the Biotech Service Sector at Bangalore Bio

Biocon bags IDMA "Best Patent of the year" award

BIOMAb EGFR® was voted µBio-Spectrum Asia-Pacific Product of

the year¶, 2008

Biocon wins prestigious BioSingapore Asia Pacific BiotechnologyAward for Best Listed Company

2008

Biocon is ranked among the top 20 global biotechnologycompanies (Source: Med Ad News, June 2008)

Biocon is the 7th largest biotech employer in the world (Source:Med Ad News, June 2008)

2007

Syngene receives "BioServices Company of the Year",

BioSpectrum Awards

Biocon's BIOMAb EGFR®

wins "Product of the Year",BioSpectrum Awards

2006

Best IT User Award in the Pharmaceutical Sector, NASSCOM

2004

India's first and No. 1 biotech company with a global ranking of 16* (Source: Biospectrum July 2004)

Biocon in India's top 5 Life Sciences companies (at close of tradeas on July 30, 2004)

Best Reinvention of HR Function Award, Indira Group, Mumbai

Best Employer Of India Award, Hewitt

2003

Bio-Business Award for bio-entrepreneurship, Rabo India

Express Pharma Pulse Award for excellence in thepharmaceutical industry

2001

Biotech Product, Process Development and CommercialisationAward, Department of Biotechnology, Ministry of Science and



Technology, Government of India

2000

Technology Pioneer Recognition, World Economic Forum

1985

Export Performance Award, Karnataka State FinancialCorporation (KSFC)

National Award for Best Small Industry, Government of India

Kiran Mazumdar-Shaw:

2010

Featured on the Forbes list of µThe World¶s 100 Most PowerfulWomen¶.

Featured on the Financial Times µTop 50 Women in Business¶ list.

Named among TIME magazine¶s 100 most influential people inthe world.

2009

Honoured with 'Nikkei Asia Prize' for Regional Growth

Honoured with 'Express Pharmaceutical Leadership SummitAward' for Dynamic Entrepreneur

2008

Honorary Degree of Doctor of Science from the Heriot-Watt

University, Edinburgh

Honorary Degree of Doctor of Science from the University of Glasgow

2007

Honoured with the, 'Veuve Clicquot Initiative For EconomicDevelopment For Asia' award

Honorary Doctor of Technology, University of Abertay, Dundee (UK )

2005

Padmabhushan Award , one of India's highest civilian honours,from the President of India, Dr. APJ Abdul Kalam

Honorary Degree of Doctor of Science (Honoris Causa) fromIndian Institute of Technology, Roorkee

The Indian Chamber of Commerce Lifetime Achievement Award

Honorary Doctorate from Manipal Academy of Higher Education(MAHE), in recognition of outstanding achievements in



biotechnology and industrial enzymes

Rotary Award for Corporate Citizenship

Business Leader of the Year Award - Biotechnology,Chemtech-Pharma Bio Awards

2004

Honorary Doctorate of Science from Ballarat University, inrecognition of pre-eminent contribution to the field of biotechnology

Business Woman Of The Year Award, The Economic Times

2003

Alumni High Achiever Award, Australian Alumni Association

2002

Karnataka Rajyotsava Award for pioneering biotechnology inIndia, the Government of Karnataka

Best Entrepreneur: Healthcare & Life Sciences Award,Ernst & Young

Sir M. Visvesvaraya Memorial Award for contributionto biotechnology, Federation of Karnataka Chambersof Commerce & Industry (FKCCI)

1999

Woman of the Year Award, International Women'sAssociation, Chennai

1998

Golden Jubilee Felicitation, Mount Carmel College, Bangalore

1989

Padmashri for pioneering biotechnology in India,Government of India

1987

Outstanding Young Person Award, Jaycees India

1983

Best Small Scale Industry in Karnataka Award, Rotary Club,Karnataka

Best Model Employer Award, Rotary Club, Karnataka

Outstanding Contribution Award, AWAKE

1982



Best Woman Entrepreneur Award, National Institute of Marketing Management, India

www.biocon.com/biocon_aboutus_awards.asp

www.iloveindia.com/indian-heroes/kiran-mazumdar-shaw

http://www.businessandeconomy.org/29122005/story

http://news.oneindia.in/2009/05/11/kiranmazumdar-shaw-awarded-prestigious-nikkei-asia-prize

http://www.innovationcouncil.gov.in/members/kiranmazumdarshaw.php

http://www.wewit.in/content/kiran-mazumdar-shaw

http://biospectrumindia.ciol.com/content/biospecial/104010801.asp

http://www.adport.net/success-stories/kiranmazumdarstory.html

http://www.business-standard.com/india/news/kiran-mazumdar-shaw-gets-veuve-clicquot-

award/301408/

http://abhayjere.com/qbt.aspx

A woman dares where men fear to tread´ is perhaps the one best way one would define the life and

struggles of India¶s biotech pioneer and Biocon chairperson Kiran Mazumdar-Shaw, who is arguably

the most influential woman entrepreneur in corporate India. As a woman who qualified as a Master

Brewer from Ballarat University, Australia, in 1975, she has certainly made tremendous strides in a

business that was, at that time, unknown to her and to the risk averse mind of the Indian

entrepreneur. Even as we trudge judiciously into her office to meet her, we realise that the perception

of biotech in India remains that of a high risk business reserved for people who can consistently pump

in heavy capital over a long term basis; and that, to us, makes Kiran¶s achievements all the more

exemplary.

Meeting Kiran Mazumdar-Shaw is quite an experience, especially after the Economist sub-titled her

India¶s Biotech Queen and Fortune placed her in the list of World¶s 50 Most Powerful Women. Well, our

greetings are quite fitting, akin to royalty. The honours have unsurprisingly kept pouring in for her,

the most important ones being the Padmashri (1989) & Padma Bhushan (2005). She is also the

Chairperson and Mission Leader of CII¶s National Task Force on Biotechnology. Apart from that, she is

president of ABLE (Association of Biotechnology Led Entrepreneurs) and chairperson, Karnataka Vision

Group on Biotechnology.

Bangalore, May 11 (ANI/Business Wire India): Kiran Mazumdar Shaw, Chairman and Managing

Director, Biocon Limited has been honoured with the 'Nikkei Asia Prize' 2009 for Regional Growth.

Japan's prestigious business daily Nihon Keizai Shimbun (Nikkei) awards Nikkei Asia Prizes

annually to individuals or institutions from Asia Pacific region recognizing outstanding achievements

that improve the quality of life in Asia.



"My vision is to grow into a global bio-therapeutics company with very innovative and proprietary

products and technologies. Two years is a very short time to predict drug discovery but we hope todiscover a few new drug molecules in three-four years through a new in-house initiative."

A successful technocrat of global standing, Ms. Shaw heads India¶s leading Biopharmaceutical enterprise,Biocon. She is highly respected in the corporate world and has recently made it to the 2010 Times 100 list,as µThe Most Influential Person¶. She was also featured on the Forbes list of ³The World¶s 100 Most Powerful

Women´. Her pioneering efforts in biotechnology have drawn global recognition both for Indian industry andBiocon.

She chairs Karnataka¶s Vision Group on Biotechnology and has also served on the Board of ScienceFoundation, Ireland. She presently serves on the Advisory Council of the Government¶s Department of Biotechnology where she has been instrumental in bringing government, industry and academia together.She is associated with the Indian Pharmacopoeia Commission, an autonomous body of the Government of India. She is also a founder member of the Society for the formation of µInstitute for Stem Cell Biology andRegenerative Medicine¶. She has recently been nominated as Member of the Board of Trade, DirectorateGeneral of Foreign Trade, Ministry of Commerce & Industry.

There are few people who can show the way among the multitudes, who are exceptional leaders. Onesuch person is Kiran Muzumdar Shaw.

Kiran is the Chairperson and Managing Director of Biocon Ltd, India's biggest biotechnology company

and one of the 20 leading biotech companies in the world.

Kiran never dreamt of becoming an entrepreneur. The cards were stacked against her: her father lost

his savings in a bad investment, she had no background in biotech or entrepreneurship, and she had

to overcome the stigma of being a female entrepreneur in the sciences. At the time of Biocon's

founding, banks were unwilling to give loans for the unfamiliar field or biotechnology.

With the help of fellow female biotech mentor and just Rs.10, 000, Kiran founded Biocon in 1978. The

company began by developing a process to extract papain, an enzyme from payaya. The fermentation

process subsequently led to the development of several other industrial enzymes. By the year 1990,Biocon became capable enough to kick-start an in-house research programme in solid substrate

fermentation technology that permitted it to create enzymes from pilot to plant level. Later, she led

the company to the realm of biopharmaceuticals fully integrated bio-pharmaceutical venture

comprising a well-balanced business assortment of products and services with specific research on

diabetes, oncology and auto-immune disease. In 2004, Biocon's unprecedented success made Kiran

India's richest woman.

Outside of business, Kiran is also a vocal spokesperson of the biotech industry. She is currently on the

Advisory Council of the Government¶s Department of Biotechnology, where she has been instrumental

in bringing together government, industry and academia in order to plan a lucid and progressive

growth path for Biotechnology in India. Most recently, she has been invited to join the Prime Minister¶s

Council on Trade & Industry in India and the US-India CEO Forum.

She is in recipient of several prestigious awards, including: The Economic Times Business Woman of

the Year Award in 2004, Lifetime Achievement Award from Indian Chamber of Commerce in 2005 and

Wharton Infosys Business Transformation Award in 2006

BioSpectrum¶s first ever Awards for the biotech industry were presented on 20 December 2003 inBangalore. A report.



"Success is one percent inspiration and 99 percent perspiration." Success is alsoappreciation²both for measure of success and enabler for greater success. Thatwas the philosophy behind BioSpectrum Awards. With this theme, the stage wasset to felicitate the achievers of the biotech industry. Well-known biotechnologyexpert and Father of India¶s Green Revolution, Prof. M S Swaminathan wasconferred the magazine¶s "Life Time Achievement" Award, while Ms KiranMazumdar-Shaw, Chairperson and Managing Director of the Rs 286-croreBiocon India, was honoured with the "BioSpectrum Person of the Year " Award.

heVisionBeyond

Back

BIOCON aims at standing as one of the top ten corporate biotech conglomerates, worldwide. Kiran ferventlyhopes to see a BIOCON molecule in the world market in the next five years, placing India in the covetedleague of rare and vibrant biotech forerunners. India is one of the biggest centers for biotechnology in theareas of health care and pharmaceuticals, she asserts.

Her vision was ratified when the Karnataka government founded a biotechnology Vision group, with Kiran asits Chairman. Kiran advises the government on the policy initiatives that it should introduce in the field of

BioSpectrum

Awards

Life Time

Achievement:

Prof. MSSwaminathan

Person of theYear: Ms KiranMazumdar-Shaw

Entrepreneur of

the Year: Dr Krishna M Ella

State of the Year: Andhra Pradesh

Product of the

Year: AVADIS



biotechnology.

Kiran has also been selected as the honorary Consul of Ireland for pharma-biotech ventures between Indiaand Ireland. The $350 billion pharmaceutical industry revolves around merely 400 drug targets, which areknown to wreck human health.

The functional genomics should explode the universe to an ambit of 10,000 targets or more. In short,

trillions of dollars of business have been set to explode globally"

a potential, which had Bill Gates(Microsoft) subscribing to it too". Kiran has identified such an opportunity and skillfully developed it to placeIndia in the global map of biotechnology.

A position as one of the top ten G-7 or G-10 countries in the world is what India should aim for, Kiran stateswith passion.

Kiran Mazumdar-Shaw gets Veuve Clicquot award

Annoucement / Mumbai October 16, 2007

Biocon has announced that Kiran Mazumdar-Shaw, Chairperson and Managing Director of the Company has beenhonoured with the 'Veuve Clicquot Initiative For Economic Development For Asia¶ award. The award for EconomicDevelopment was introduced for the first time in 2007. There were three Economic Development awards that went tothree women from Asia (India) Latin America (Bolivia) and Africa (Algeria). This is a special award that looks beyondbusiness success to CSR and a combined effort to bring about economic change in developing economies. Ms. Kiran

Mazumdar-Shaw has been nominated as the very first winner for Asia. Ms. Shaw was presented the award at Reims,one hour away from Paris over a unique two-day function.

One of the first steps Kiran took was to set up an office in a small garage and advertise for staff. To her

chagrin, she found that instead of interviewing people, she was being interviewed by them! Few liked the

idea of working for a woman, that too one who was so young (she was 25). Even more difficult was

getting capital to begin the venture. Although there were government schemes for funding small scale

industries, Kiran was time and again turned away from banks unwilling to give a loan to a woman with a

risky venture in an unheard of field. She did eventually get a financial backer, but it took years before

Kirans skills and vision got the company to its peak.

When it eventually did, Biocon stormed the world, having grown from a small company producing

industrial enzymes to a mammoth biopharmaceutical company which ventured into innovative research

programs. From a $250 start-up company to a $1 billion venture, Biocon Ltd. has made a huge impact onthe lives of ordinary people.

Under the mentorship of Kiran, the company focuses on insulin, antibodies and cancer vaccines with the

aim to create drugs which are affordable especially to the poor of India. When TIME magazine named

Kiran in its annual list of the 100 most influential people in the world, cyclist Lance Armstrong wrote

Thank you, Dr. Shaw, for treating cancer like the global crisis it has become. Kiran is a true

philanthropist, donating about $2 million towards health insurance coverage for villagers in India. She

also provided $10 million as funds to set up the Mazumdar-Shaw Cancer Centre inBangalore; it will

provide free treatment to poor patients. In fact, Kiran featured in Forbes magazines list of Asias top

philanthropists.

http://www.hi5sms.in/kiran-mazumdar-richest-indian-lady-hi5sms-in.php

kiran mazumdar shaw is the chairman

Documents